ONCOLOGY

Big Ten big news

Big Ten Cancer Research Consortium formed

issue 19 | Fall 2013

In athletics, the Big Ten universities compete against each other, but now many will join together against a common foe — cancer.

Leaders from the University of Michigan Comprehensive Cancer Center and other Big Ten universities' cancer centers have formed the Big Ten Cancer Research Consortium to transform cancer research through collaborative oncology trials that leverage the scientific and clinical expertise of the Big Ten universities.

“For research to be truly impactful, we must work together. Collaborating with other institutions gives us another opportunity for a broader and deeper brain trust while allowing implementation of novel ideas in a more representative patient population,” says Maha Hussain, M.D., FACP, associate director of clinical research at the University of Michigan Comprehensive Cancer Center.

The clinical trials that will be developed will be linked to molecular diagnostics, enabling researchers to understand what drives the cancers to grow and what might be done to stop them from growing.